These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 7729959)
1. The von Hippel-Lindau (VHL) disease tumor-suppressor gene is not mutated in nasopharyngeal carcinomas. Sun Y; Hildesheim A; Li H; Lanier AP; Cao Y; Yao KT; Yang CS; Colburn NH Int J Cancer; 1995 May; 61(3):437-8. PubMed ID: 7729959 [No Abstract] [Full Text] [Related]
2. VHL gene inactivation in an endolymphatic sac tumor associated with von Hippel-Lindau disease. Kawahara N; Kume H; Ueki K; Mishima K; Sasaki T; Kirino T Neurology; 1999 Jul; 53(1):208-10. PubMed ID: 10408561 [TBL] [Abstract][Full Text] [Related]
3. Molecular genetic analysis of the von Hippel-Lindau disease (VHL) tumour suppressor gene in gonadal tumours. Foster K; Osborne RJ; Huddart RA; Affara NA; Ferguson-Smith MA; Maher ER Eur J Cancer; 1995 Dec; 31A(13-14):2392-5. PubMed ID: 8652274 [TBL] [Abstract][Full Text] [Related]
4. Endolymphatic sac tumors in patients with and without von Hippel-Lindau disease: the role of genetic mutation, von Hippel-Lindau protein, and hypoxia inducible factor-1alpha expression. Jensen RL; Gillespie D; House P; Layfield L; Shelton C J Neurosurg; 2004 Mar; 100(3):488-97. PubMed ID: 15035285 [TBL] [Abstract][Full Text] [Related]
5. Von Hippel-Lindau disease and sporadic renal cell carcinoma. Zbar B Cancer Surv; 1995; 25():219-32. PubMed ID: 8718521 [TBL] [Abstract][Full Text] [Related]
6. Frequent allelic loss at chromosome arm 3p is distinct from genetic alterations of the Von-Hippel Lindau tumor suppressor gene in head and neck cancer. Waber PG; Lee NK; Nisen PD Oncogene; 1996 Jan; 12(2):365-9. PubMed ID: 8570213 [TBL] [Abstract][Full Text] [Related]
7. Von Hippel-Lindau disease: how does one gene cause multiple tumors? Roach ES Neurology; 1999 Jul; 53(1):7-8. PubMed ID: 10408528 [No Abstract] [Full Text] [Related]
8. Somatic mutations of the von Hippel-Lindau disease tumour suppressor gene in non-familial clear cell renal carcinoma. Foster K; Prowse A; van den Berg A; Fleming S; Hulsbeek MM; Crossey PA; Richards FM; Cairns P; Affara NA; Ferguson-Smith MA Hum Mol Genet; 1994 Dec; 3(12):2169-73. PubMed ID: 7881415 [TBL] [Abstract][Full Text] [Related]
11. A PCR generated AccI RFLP in the 3' untranslated region of the von Hippel-Lindau disease (VHL) tumour suppressor gene. Payne SJ; Richards FM; Maher ER Hum Mol Genet; 1994 Feb; 3(2):390. PubMed ID: 7911705 [No Abstract] [Full Text] [Related]
12. Long polymerase chain reaction in detection of germline deletions in the von Hippel-Lindau tumour suppressor gene. Cybulski C; Krzystolik K; Maher ER; Richard S; Kurzawski G; Gronwald J; Lubiński J Hum Genet; 1999 Oct; 105(4):333-6. PubMed ID: 10543401 [TBL] [Abstract][Full Text] [Related]
13. Chromosome 3p deletion in a renal cell carcinoma cell line established from a patient with von Hippel-Lindau disease. Kohno T; Sekine T; Tobisu K; Oshimura M; Yokota J Jpn J Clin Oncol; 1993 Aug; 23(4):226-31. PubMed ID: 8105119 [TBL] [Abstract][Full Text] [Related]
14. Von Hippel-Lindau gene alterations in sporadic benign and malignant pheochromocytomas. Dannenberg H; De Krijger RR; van der Harst E; Abbou M; IJzendoorn Y; Komminoth P; Dinjens WN Int J Cancer; 2003 Jun; 105(2):190-5. PubMed ID: 12673678 [TBL] [Abstract][Full Text] [Related]
15. Detailed mapping of germline deletions of the von Hippel-Lindau disease tumour suppressor gene. Richards FM; Crossey PA; Phipps ME; Foster K; Latif F; Evans G; Sampson J; Lerman MI; Zbar B; Affara NA Hum Mol Genet; 1994 Apr; 3(4):595-8. PubMed ID: 8069305 [TBL] [Abstract][Full Text] [Related]
16. [Mapping of human chromosome 3 and its application to human diseases]. Yamakawa K; Nakamura Y; Takahashi E Tanpakushitsu Kakusan Koso; 1993 Feb; 38(3):215-27. PubMed ID: 8098152 [No Abstract] [Full Text] [Related]
17. Adapted whole-body surveillance for von Hippel-Lindau-associated tumors in 3p deletion syndrome with VHL deletion: A case report. Morisawa K; Sato T; Shimoyamada M; Mizuno R; Ohashi H; Watanabe-Hisazumi H; Takeshima K; Kojima A; Sato S; Hasegawa T; Takahashi T Pediatr Blood Cancer; 2022 Nov; 69(11):e29732. PubMed ID: 35441425 [No Abstract] [Full Text] [Related]
18. Localization of the von Hippel-Lindau disease gene to a small region of chromosome 3. Hosoe S; Brauch H; Latif F; Glenn G; Daniel L; Bale S; Choyke P; Gorin M; Oldfield E; Berman A Genomics; 1990 Dec; 8(4):634-40. PubMed ID: 2276737 [TBL] [Abstract][Full Text] [Related]
19. Second hit deletion size in von Hippel-Lindau disease. Gläsker S; Sohn TS; Okamoto H; Li J; Lonser RR; Oldfield EH; Vortmeyer AO; Zhuang Z Ann Neurol; 2006 Jan; 59(1):105-10. PubMed ID: 16261628 [TBL] [Abstract][Full Text] [Related]
20. Identification of cyclin D1 and other novel targets for the von Hippel-Lindau tumor suppressor gene by expression array analysis and investigation of cyclin D1 genotype as a modifier in von Hippel-Lindau disease. Zatyka M; da Silva NF; Clifford SC; Morris MR; Wiesener MS; Eckardt KU; Houlston RS; Richards FM; Latif F; Maher ER Cancer Res; 2002 Jul; 62(13):3803-11. PubMed ID: 12097293 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]